功能化的光免疫水凝微球用于通过PD-L1 PROTAC战略从内到外根除骨肉瘤
Huanhuan Luo1,2, Jun Ma2, Haiyang Yang2,3
1Central Laboratory, The Second Affiliated Hospital of Jiaxing University, Jiaxing, P. R. China.
Advanced healthcare materials
|November 22, 2025
概括
这项研究介绍了CP-MOF@gel,一种用于骨髓瘤治疗的新型免疫凝微球. 它精确地降解PD-L1蛋白,逆转免疫抑制性瘤微环境并增强免疫治疗结果.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 免疫学 免疫学 免疫学
背景情况:
- 骨髓瘤免疫疗法受到免疫抑制性瘤微环境的阻碍.
- 准PD-L1是增强抗瘤免疫力的关键策略.
研究的目的:
- 开发一种新的免疫凝微球 (CP-MOF@gel),用于精确降解骨髓瘤中PD-L1蛋白质.
- 研究CP-MOF@gel在逆转免疫抑制瘤微环境和增强免疫疗法的有效性.
主要方法:
- 合成了封装Cypate和PROTAC PD-L1降解剂 (ppd) 的核心纳米粒子.
- 使用微流体和光固化技术创建了CP-MOF@gel.
- 在体外和体外的研究评估了该系统的药物释放,ROS生成,光热效应,热致死诱导和抗瘤免疫力.
主要成果:
- CP-MOF@gel证明了优化的合成,提高了药物负载和减少了颗粒大小.
- 该系统有效地释放了CP-MOF,触发了热,并在辐射时诱导了光热效应.
- 在体内,CP-MOF@gel显著增强了T细胞中介杀死,改善了免疫治疗结果.
结论:
- CP-MOF@gel提供了基于PROTAC的精密蛋白质降解策略,用于抑制骨髓瘤.
- 这种"内外"的治疗方法有效地逆转了免疫抑制瘤微环境.
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


